Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: CP-506|DRUG: Carboplatin|DRUG: Immune checkpoint inhibitor
Sponsor: Maastricht University
Collaborators: Erasmus Medical Center|Jules Bordet Institute|Academisch Ziekenhuis Maastricht